← Back
Data updated: Mar 29, 2026
LPI
OncologyImmunology
Generics
LPI is a generic drug manufacturer focused on Oncology, Immunology.
1987
Since
2
Drugs
-
Trials
0
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
No recent activity
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 76%
0 drugs Phase 2: 1 Phase 1: 11
Immunology 24%
0 drugs Phase 2: 1 Phase 1: 2
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Active (0)
Discontinued (2)
Company Info
- First Approval
- 1987-12-14
- Latest
- 1987-12-14
- Applications
- 2